These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2894041)

  • 1. The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs.
    Steru L; Chermat R; Thierry B; Mico JA; Lenegre A; Steru M; Simon P; Porsolt RD
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(6):659-71. PubMed ID: 2894041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the automated tail suspension test for the primary screening of psychotropic agents.
    Porsolt RD; Chermat R; Lenègre A; Avril I; Janvier S; Stéru L
    Arch Int Pharmacodyn Ther; 1987 Jul; 288(1):11-30. PubMed ID: 2889430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tail suspension test: a new method for screening antidepressants in mice.
    Steru L; Chermat R; Thierry B; Simon P
    Psychopharmacology (Berl); 1985; 85(3):367-70. PubMed ID: 3923523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
    Worms P; Kan JP; Wermuth CG; Roncucci R; Bizière K
    J Pharmacol Exp Ther; 1987 Jan; 240(1):241-50. PubMed ID: 3100770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The tail suspension test: its theory and practical application].
    Nomura S; Naruse R; Okada H
    Yakubutsu Seishin Kodo; 1992 Oct; 12(5):207-13. PubMed ID: 1295276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in the behavioural 'despair' test in rats.
    Borsini F; Pulvirenti L; Samanin R
    Eur J Pharmacol; 1985 Apr; 110(2):253-6. PubMed ID: 3987815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test.
    Varty GB; Cohen-Williams ME; Hunter JC
    Behav Pharmacol; 2003 Feb; 14(1):87-95. PubMed ID: 12576885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of the learned helplessness model of depression.
    Sherman AD; Sacquitne JL; Petty F
    Pharmacol Biochem Behav; 1982 Mar; 16(3):449-54. PubMed ID: 7200610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
    Burkard WP; Bonetti EP; Da Prada M; Martin JR; Polc P; Schaffner R; Scherschlicht R; Hefti F; Müller RK; Wyss PC
    J Pharmacol Exp Ther; 1989 Jan; 248(1):391-9. PubMed ID: 2913284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new behavioral test for antidepressant drugs.
    Nomura S; Shimizu J; Kinjo M; Kametani H; Nakazawa T
    Eur J Pharmacol; 1982 Sep; 83(3-4):171-5. PubMed ID: 7173309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-immobility activity of different antidepressant drugs using the tail suspension test in normal or reserpinized mice.
    Teste JF; Pelsy-Johann I; Decelle T; Boulu RG
    Fundam Clin Pharmacol; 1993; 7(5):219-26. PubMed ID: 8370568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tail suspension test does not detect antidepressant-like properties of atypical antipsychotics.
    Wesołowska A; Partyka A; Jastrzębska-Więsek M; Kolarz A; Mierzejewski P; Bieńkowski P; Kołaczkowski M
    Behav Pharmacol; 2011 Feb; 22(1):7-13. PubMed ID: 21127415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant-like effect of Cordyceps sinensis in the mouse tail suspension test.
    Nishizawa K; Torii K; Kawasaki A; Katada M; Ito M; Terashita K; Aiso S; Matsuoka M
    Biol Pharm Bull; 2007 Sep; 30(9):1758-62. PubMed ID: 17827735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of various classes of antidepressants in behavioral paradigms of despair.
    Kulkarni SK; Dhir A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1248-54. PubMed ID: 17570574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral despair in mice: a primary screening test for antidepressants.
    Porsolt RD; Bertin A; Jalfre M
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):327-36. PubMed ID: 596982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse.
    Castagné V; Porsolt RD; Moser P
    Eur J Pharmacol; 2009 Aug; 616(1-3):128-33. PubMed ID: 19549518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The additive effects of quinine on antidepressant drugs in the forced swimming test in mice.
    Guo WY; Todd KG; Bourin M; Hascoet M
    Psychopharmacology (Berl); 1995 Sep; 121(2):173-9. PubMed ID: 8545522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic administration of antidepressants on duration of immobility in rats forced to swim.
    Kawashima K; Araki H; Aihara H
    Jpn J Pharmacol; 1986 Feb; 40(2):199-204. PubMed ID: 2871209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain differences in response to drugs in the tail suspension test for antidepressant activity.
    van der Heyden JA; Molewijk E; Olivier B
    Psychopharmacology (Berl); 1987; 92(1):127-30. PubMed ID: 3110823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.